A rare case of acute lymphoblastic leukemia in a patient with light chain (AL) amyloidosis treated with lenalidomide

Nair, Ranjit; Gheith, Shereen; Popescu, Dan; Agostino, Nicole M.
May 2014
International Journal of Clinical & Experimental Pathology;2014, Vol. 7 Issue 5, p2683
Academic Journal
No abstract available.


Related Articles

  • Lenalidomide.  // Reactions Weekly;Mar2015, Vol. 1543 Issue 1, p149 

    The article presents a case study of a 73-year-old woman who developed acute lymphoblastic leukaemia (ALL) after receiving lenalidomide treatment for renal light-chain amyloidosis.

  • Bortezomib/cyclophosphamide/dexamethasone.  // Reactions Weekly;Nov2015, Vol. 1579 Issue 1, p87 

    The article describes the case a patient who developed autonomic neuropathy after treatment with bortezomib, cyclophosphamide and dexamethasone for amyloid light chain (AL) amyloidosis, referencing research published in the journal "Clinical Lymphoma, Myeloma & Leukemia."

  • Sudden death possibly related to lenalidomide given for cardiac and muscle AL amyloidosis secondary to light chain deposition disease. Finsterer, Josef; Höftberger, Romana; Stöllberger, Claudia; Wöhrer, Adelheid; Regele, Heinz // Journal of Oncology Pharmacy Practice;Jun2013, Vol. 19 Issue 2, p170 

    Objectives: Restrictive cardiomyopathy due to AL amyloidosis has not been reported as the cause of sudden death. The risk of sudden death in AL amyloidosis may be further increased by potentially cardiotoxic medication, as in the following case. Case report: In a 69-year-old female, AL...

  • Amyloidosis of the breast: predominantly AL type and over half have concurrent breast hematologic disorders. Said, Samar M; Reynolds, Carol; Jimenez, Rafael E; Chen, Beiyun; Vrana, Julie A; Theis, Jason D; Dogan, Ahmet; Shah, Sejal S // Modern Pathology;Feb2013, Vol. 26 Issue 2, p232 

    No abstract available.

  • Spontaneous Rupture of Spleen in Immunoglobulin Light Chain Amyloidosis: A Case Report and Review of Literature. Taneja, Sunil; Ranjan, Piyush; Khanna, Sanjay; Vasdev, Nandini; Sama, S. K.; Arora, Anil // Euroasian Journal of Hepato-Gastroenterology;Jul-Dec2011, Vol. 1 Issue 2, p100 

    Rupture of spleen in absence of trauma is very rare and can occur in certain pathologic conditions. Amyloidosis involves spleen and splenomegaly has been reported in 4 to 13% of patients; however, splenic rupture has rarely been reported in amyloidosis. Here, we report a case of spontaneous...

  • Two cases of hypereosinophilia and high-risk acute lymphoblastic leukemia. Sutton, R; Lonergan, M; Tapp, H; Venn, N C; Haber, M; Norris, M D; O'Brien, T A; Alvaro, F; Revesz, T // Leukemia (08876924);Jul2008, Vol. 22 Issue 7, p1463 

    This article discusses cases of acute lymphoblastic leukemia (ALL) and symptomatic eosinophilia in children. In these cases, the patients received chemotherapy and bone marrow transplants, with the eosinophilia coming from the donor marrow. These cases are described as a rare and aggressive...

  • Is B-Lineage Acute Lymphoblastic Leukemia With a Mature Phenotype and L1 Morphology a Precursor B-Lymphoblastic Leukemia/Lymphoma or Burkitt Leukemia/Lymphoma? Shiyong Li, Glen; Lew // Archives of Pathology & Laboratory Medicine;Oct2003, Vol. 127 Issue 10, p1340 

    Context.--B-lineage acute lymphoblastic leukemia (ALL) with a mature phenotype and L1 morphology is a rare condition that may pose a diagnostic and management challenge. Objective.--To report our experience with 2 such unusual cases of pediatric B-lineage ALL. Design.--Morphologic,...

  • Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib, and thalidomide. Palladini, Giovanni; Russo, Paola; Foli, Andrea; Milani, Paolo; Lavatelli, Francesca; Obici, Laura; Nuvolone, Mario; Brugnatelli, Silvia; Invernizzi, Rosangela; Merlini, Giampaolo // Annals of Hematology;Jan2012, Vol. 91 Issue 1, p89 

    The increasing number of effective agents allows rescue therapy of patients with light-chain (AL) amyloidosis refractory to ≥2 previous treatments. Lenalidomide is effective in this disease and its toxicity profile encourages its use in salvage regimens. All the patients with AL...

  • Three further cases of t(8;14)(q11.2;q32) in acute lymphoblastic leukemia. Byatt, S-A; Cheung, K-L; Lillington, D M; Mazzullo, H; Martineau, M; Bennett, C; Roberts, K; Harewood, L; Sumption, N; Humphreys, M; Burrett, J; Harrison, C J // Leukemia (08876924);Aug2001, Vol. 15 Issue 8, p1304 

    Focuses on three cases of acute lymphoblastic leukemia with rare chromosomal translocation in Great Britain. Identification of patients through Acute Lymphoblastic Leukemia database; Cytogenetic analysis on diagnostic bone marrow samples in laboratories; Chromosomal changes observed in the...

  • Lenalidomide.  // Reactions Weekly;Dec2015, Vol. 1580 Issue 1, p227 

    The article describes the case of a 52-year-old female patient who developed pleural and pericardial effusions after being treated for acute myeloid leukemia with lenalidomide.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics